clearn.png
Monday June 17th, 2019 6:49AM

Study finds diabetes drug may prevent, slow kidney disease

By The Associated Press

A drug that's used to help control blood sugar in people with diabetes has now been shown to help prevent or slow kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive.

Doctors say it's hard to overstate the importance of this study, and what it means for curbing this problem, which is growing because of the obesity epidemic.

The study tested Janssen Pharmaceuticals' drug Invokana. Results were discussed Sunday at a medical meeting in Australia and published by the New England Journal of Medicine.

About 30 million Americans and more than 420 million people worldwide have diabetes , and most cases are Type 2, the kind tied to obesity. It occurs when the body can't make enough or properly use insulin, which turns food into energy.

This can damage the kidneys over time, causing disease and ultimately, failure. In the U.S., it's responsible for nearly half a million people needing dialysis, and for thousands of kidney transplants each year.

Some blood pressure drugs lower this risk but they're only partially effective. The new study tested Invokana, a daily pill sold now to help control blood sugar, to see if it also could help prevent kidney disease when added to standard treatments.

For the study, about 13,000 people with Type 2 diabetes and chronic kidney disease from around the world were to be given Invokana or dummy pills. Independent monitors stopped the study early, after 4,400 people had been treated for about 2.5 years on average, when it was clear the drug was helping.

Those on the drug had a 30% lower risk of one of these problems — kidney failure, need for dialysis, need for a kidney transplant, death from kidney- or heart-related causes, or other signs that kidneys were failing.

For every 1,000 people taking the drug for 2.5 years, there would be 47 fewer cases of one of these problems, researchers estimate.

Rates of serious side effects were similar in the drug and placebo groups including leg, foot or toe amputations, a concern raised by a previous study of Invokana. One side effect, when the body can't produce enough insulin, was more frequent among those on Invokana but rare overall.

Janssen, which is part of Johnson & Johnson, sponsored the study and many authors work or consult for the company. The drug costs about $500 a month in the U.S. Out-of-pocket costs for patients may be different, depending on insurance.

The importance of this large and well-done study "cannot be overstated," Drs. Julie Ingelfinger and Clifford Rosen, editors at the medical journal, wrote in an accompanying article.

In recent years, several studies have found that Invokana and some similar drugs can lower heart risks. The new results, showing that Invokana also may stall or prevent kidney failure, expand the potential benefits of the drug.

___

Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Health, AP Business
© Copyright 2019 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Coast Guard: 23 adrift for days rescued in Gulf of Mexico
The U.S. Coast Guard says it worked with a cruise ship to rescue 23 people adrift for day in the Gulf of Mexico
8:05PM ( 10 minutes ago )
'Mayor Pete' joins 2020 Dem race as face of new generation
Pete Buttigieg, the little-known Indiana mayor who has risen to prominence in the early stages of the 2020 Democratic presidential race, has made his official campaign entrance by claiming the mantle of a fresh generation ready to reshape the country
7:44PM ( 31 minutes ago )
Home-court advantage? Warriors had it, now 76ers need it
Opening day of the NBA postseason was no time to be home
7:35PM ( 40 minutes ago )
Associated Press (AP)
Social Democrats, populists top Finland vote ahead of EU's
Results from Finland's parliamentary election have displayed the struggle by Europe's traditional political parties to retain supporters
7:06PM ( 1 hour ago )
The Latest: Populist party amazed by Finland election result
Chairman of populist Finns Party says he's surprised at how he and his party performed in Finland's parliamentary election
5:39PM ( 2 hours ago )
The Latest: Center-left Finnish party hails narrow win
The leader of Finland's center-left Social Democratic Party vowed to focus on climate and social policies after election results indicated his party won the most seats in parliament
5:05PM ( 3 hours ago )
AP Business
Coast Guard: 23 adrift for days rescued in Gulf of Mexico
The U.S. Coast Guard says it worked with a cruise ship to rescue 23 people adrift for day in the Gulf of Mexico
8:05PM ( 10 minutes ago )
'Mayor Pete' joins 2020 Dem race as face of new generation
Pete Buttigieg, the little-known Indiana mayor who has risen to prominence in the early stages of the 2020 Democratic presidential race, has made his official campaign entrance by claiming the mantle of a fresh generation ready to reshape the country
7:44PM ( 31 minutes ago )
Home-court advantage? Warriors had it, now 76ers need it
Opening day of the NBA postseason was no time to be home
7:35PM ( 40 minutes ago )
APNewsBreak: Trump campaign to report $30 million haul
President Donald Trump's reelection campaign is set to report raising more than $30 million in for first quarter of 2019, slightly more than his two top Democratic rivals combined
7:17PM ( 58 minutes ago )
20 years on, Solskjaer hopes for another Camp Nou comeback
Manchester United manager Ole Gunnar Solskjaer is looking to overturn another Champions League deficit at the Camp Nou
7:14PM ( 1 hour ago )